InvestorsHub Logo
Post# of 890
Next 10
Followers 480
Posts 60094
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Thursday, 11/18/2021 10:29:40 PM

Thursday, November 18, 2021 10:29:40 PM

Post# of 890
A Tale of Two Protease Inhibitors...

Protease inhibitors bind to a viral enzyme (called a protease), preventing the virus from replicating in the cell. Protease inhibitors have been effective at treating other viral pathogens such as HIV and hepatitis C virus, both alone and in combination with other antivirals. Currently marketed therapeutics that target viral proteases are not generally associated with toxicity and as such, this class of molecules may potentially provide well-tolerated treatments against COVID-19.



https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-1-study-novel-oral-antiviral


Our government to spend billions on it up front, $300-$500 per course..

Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill: WaPo


https://www.fiercepharma.com/pharma/breaking-pfizer-line-for-5b-covid-pill-deal-report?oly_enc_id=8453B4904223J5S





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.